TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Tianda Pharmaceuticals Ltd. ( (HK:0455) ) has issued an update.
Tianda Pharmaceuticals Ltd. reported its unaudited interim results for the first half of 2025, showing a decrease in revenue from HK$156,073,000 in 2024 to HK$136,635,000 in 2025. The company experienced a loss of HK$33,501,000 for the period, compared to a loss of HK$27,225,000 in the previous year, indicating challenges in maintaining profitability. Despite the financial losses, the company noted improvements in other comprehensive income, with a total comprehensive loss of HK$20,165,000, which is an improvement from the HK$41,924,000 loss in 2024.
More about Tianda Pharmaceuticals Ltd.
Tianda Pharmaceuticals Ltd. is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. It focuses on the development, manufacturing, and distribution of pharmaceutical products.
Average Trading Volume: 172,222
Technical Sentiment Signal: Hold
Current Market Cap: HK$387M
See more data about 0455 stock on TipRanks’ Stock Analysis page.